Pacific Biosciences of California, Inc. Fourth Quarter 2020 Financial Results Call

MENLO PARK, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial results on Wednesday, February 10, 2021, at 4:30pm Eastern Time. The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/. Date:... Read more

Pacific Biosciences of California, Inc. Fourth Quarter 2020 Financial Results Call

MENLO PARK, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial results on Wednesday, February 10, 2021, at 4:30pm Eastern Time.The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/.Date: February 10,... Read more

Pacific Biosciences of California, Inc. Fourth Quarter 2020 Financial Results Call

MENLO PARK, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial results on Wednesday, February 10, 2021, at 4:30pm Eastern Time. The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/. Date:... Read more

Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, 2021

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, 2021 AUSTIN, Texas, Jan. 27, 2021 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the fourth quarter ended December 31, 2020... Read more

BD Names CEO Tom Polen as Chairman of the Board

Polen to Succeed Vince Forlenza Effective April 28 FRANKLIN LAKES, N.J., Jan. 26, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Tom Polen, BD CEO and president, will assume additional responsibility as chairman of the BD board of directors, effective April 28, 2021. Polen will succeed Vincent A. Forlenza, who... Read more

HORIBA FRANCE opens a new R&D and production site

01/22/2021 |   News On January 4, 2021, HORIBA FRANCE SAS, the world leader in Raman spectroscopy, inaugurated its new site in Loos, Hauts-de-France. Formerly located in Villeneuve d’Ascq, this production and R&D site will enable the company to meet the increasing demand for Raman spectroscopy and now its flagship product, LabRAM Soleil™, which was commercially launched in... Read more

QIAGEN plans to resubmit EUA submission in the U.S. for QIAreach SARS CoV-2 Antigen Test in the first quarter of 2021

GERMANTOWN, Maryland, and HILDEN, Germany, January 20 2021–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it plans to resubmit in the first quarter of 2021 its QIAreach SARS CoV-2 Antigen Test to the U.S. Food and Drug Administration for Emergency Use Authorization to detect SARS-CoV-2 antigens in people with active infections in... Read more